Breaking News Instant updates and real-time market news.

AKCA

Akcea Therapeutics

$30.66

-1.22 (-3.83%)

16:07
10/04/18
10/04
16:07
10/04/18
16:07

Akcea Therapeutics announces Canadian approval of Tegseditm

Akcea Therapeutics (AKCA), an affiliate of Ionis Pharmaceuticals, and Ionis Pharmaceuticals (IONS), announced that Tegseditm is now approved in Canada for the treatment of stage 1 or stage 2 polyneuropathy in adult patients with hereditary transthyretin amyloidosis.

AKCA Akcea Therapeutics
$30.66

-1.22 (-3.83%)

09/18/18
NEED
09/18/18
INITIATION
Target $45
NEED
Buy
Akcea Therapeutics initiated with a Buy at Needham
Needham analyst Chad Messer initiated Akcea Therapeutics (AKCA) with a Buy rating and a price target of $45, saying it is an "attractive" way for investors to leverage "decades of innovation" by the parent Ionis Pharma (IONS) through ownership of its most advanced-stage programs. The analyst cites the unfolding "breakthrough" in the approval of a new class of antisense drugs which "directly block protein synthesis in cells by binding to RNA". Messer adds that Akcea is positioned for near-term commercial opportunity for its Tegsedi and Waylivra programs.
08/28/18
STFL
08/28/18
NO CHANGE
STFL
Hold
CRL for Waylivra 'somewhat of a surprise,' says Stifel
Stifel analyst Paul Matteis said the complete response letter for Ionis Pharmaceuticals (IONS) and Akcea Therapeutics' (AKCA) Waylivra was "somewhat of a surprise" given the positive advisory committee decision, though he also noted that "safety was acutely in focus" during the committee meeting. The basis of the CRL is not yet known and Akcea was "close to the vest" on its nature, leading Matteis to remove Waylivra from his valuations for the two stocks. Doing that lowered his Akcea price target to $25 from $33 and cut his Ionis target to $45 from $47. However, he thinks the main investor question will be regarding read-through to Tegsedi and Matteis' assumption for its approval remains unchanged, he added. The analyst keeps Hold ratings on Ionis and Akcea shares, which are down 12.5% and 29%, respectively, in pre-market trading.
08/28/18
RILY
08/28/18
NO CHANGE
Target $230
RILY
Buy
Ionis CRL positive for Alnylam's Onpattro, says B. Riley FBR
B. Riley FBR analyst Madhu Kumar believes the complete response letter for Ionis Pharmaceuticals' (IONS) and Akcea Therapeutics' (AKCA) Waylivra is positive for Alnylam Pharmaceuticals' (ALNY) Onpattro. The analyst reiterates a Buy rating on Alnylam with a $230 price target.
08/28/18
HCWC
08/28/18
NO CHANGE
HCWC
Neutral
Ionis CRL for Waylivra raises questions on Tegsedi approval, says JPMorgan
Ionis Pharmaceuticals (IONS) announced last night that its subsidiary Akcea Therapeutics (AKCA) received a complete response letter for Waylivra from the FDA. JPMorgan analyst Jessica Fye says she had a chance to catch up with management but that they did not provide much in the way of details regarding the CRL. Given that Waylivra and Tegsedi are both generation 2.5 products and both have had platelet safety issues, the market will naturally question if the risk of a CRL also extends to Tegsedi, Fye tells investors in a research note. The analyst expects Ionis shares to reflect greater risk to approval for Tegsedi as well as Waylivra. She notes that Waylivra is worth $2 per share in her model for Ionis while Tegsedi contributes greater than $10 per share. The stock in premarket trading is down 12%, or $6.68, to $47.02. Fye keeps a Neutral rating on Ionis Pharmaceuticals.

TODAY'S FREE FLY STORIES

NCNA

NuCana

$6.01

-1.24 (-17.10%)

13:02
08/20/19
08/20
13:02
08/20/19
13:02
Recommendations
NuCana analyst commentary  »

NuCana trial enrollment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

MRSN

Mersana Therapeutics

$2.66

-0.05 (-1.85%)

13:00
08/20/19
08/20
13:00
08/20/19
13:00
Recommendations
Mersana Therapeutics analyst commentary  »

H.C. Wainwright says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTE

PolarityTE

$5.27

0.08 (1.54%)

12:57
08/20/19
08/20
12:57
08/20/19
12:57
Hot Stocks
PolarityTE granted Canadian patent related to micro-aggregate technology »

PolarityTE announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 21

    Aug

  • 09

    Sep

CFBI

Community First Bancshares

$10.15

(0.00%)

12:54
08/20/19
08/20
12:54
08/20/19
12:54
Hot Stocks
Community First to acquire ABB Financial for $7.50 per share »

Community First…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCI

Navigant Consulting

$27.82

0.01 (0.04%)

12:53
08/20/19
08/20
12:53
08/20/19
12:53
Downgrade
Navigant Consulting rating change  »

Navigant Consulting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

12:45
08/20/19
08/20
12:45
08/20/19
12:45
General news
FX Action: USD-JPY »

FX Action: USD-JPY dipped…

12:36
08/20/19
08/20
12:36
08/20/19
12:36
Conference/Events
Wolfe Research healthcare analysts to hold an analyst/industry webcast »

Global Pharma Analyst…

HAIN

Hain Celestial

$19.25

-2.63 (-12.02%)

, MKC

McCormick

$161.08

-7.445 (-4.42%)

12:32
08/20/19
08/20
12:32
08/20/19
12:32
On The Fly
Beyond Meat rises after JPMorgan says buy as stock 'appealing once again' »

Shares of Beyond Meat…

HAIN

Hain Celestial

$19.25

-2.63 (-12.02%)

MKC

McCormick

$161.08

-7.445 (-4.42%)

CPB

Campbell Soup

$42.95

-0.22 (-0.51%)

BYND

Beyond Meat

$154.10

9.66 (6.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 30

    Aug

  • 15

    Sep

  • 01

    Oct

NTDOY

Nintendo

$0.00

(0.00%)

, SNE

Sony

$55.85

0.14 (0.25%)

12:30
08/20/19
08/20
12:30
08/20/19
12:30
On The Fly
Game On: Sony acquires 'Spider-Man' developer Insomniac »

NEW RELEASES: Among the…

NTDOY

Nintendo

$0.00

(0.00%)

SNE

Sony

$55.85

0.14 (0.25%)

MSFT

Microsoft

$138.41

-0.02 (-0.01%)

FB

Facebook

$184.56

-1.66 (-0.89%)

EA

Electronic Arts

$92.54

1.64 (1.80%)

TTWO

Take-Two

$131.17

1.3 (1.00%)

ATVI

Activision Blizzard

$48.44

0.53 (1.11%)

GOOG

Alphabet

$1,192.07

-5.94 (-0.50%)

GOOGL

Alphabet Class A

$1,194.00

-5.94 (-0.50%)

UBSFY

Ubisoft

$0.00

(0.00%)

SLGG

Super League Gaming

$6.65

-0.09 (-1.34%)

TCEHY

Tencent

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 21

    Aug

  • 04

    Sep

  • 05

    Sep

  • 10

    Sep

  • 12

    Sep

  • 15

    Sep

  • 18

    Sep

  • 24

    Sep

  • 27

    Oct

  • 13

    Nov

12:30
08/20/19
08/20
12:30
08/20/19
12:30
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

HD

Home Depot

$217.43

9.455 (4.55%)

12:29
08/20/19
08/20
12:29
08/20/19
12:29
Recommendations
Home Depot analyst commentary at RBC Capital »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

ABCB

Ameris Bancorp

$36.48

-0.34 (-0.92%)

12:27
08/20/19
08/20
12:27
08/20/19
12:27
Conference/Events
Ameris Bancorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 23

    Sep

SABR

Sabre

$23.68

-0.25 (-1.04%)

12:25
08/20/19
08/20
12:25
08/20/19
12:25
Periodicals
DOJ to file suit to block Sabre acquisition of Farelogix, CNBC reports »

The Fly notes that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
08/20/19
08/20
12:25
08/20/19
12:25
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

LPLA

LPL Financial

$73.06

-0.35 (-0.48%)

12:17
08/20/19
08/20
12:17
08/20/19
12:17
Conference/Events
LPL Financial management to meet with William Blair »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 12

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
08/20/19
08/20
12:17
08/20/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
08/20/19
08/20
12:16
08/20/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$212.30

1.98 (0.94%)

, NFLX

Netflix

$300.38

-9.02 (-2.92%)

12:13
08/20/19
08/20
12:13
08/20/19
12:13
Periodicals
Apple looks to launch Apple TV+ in November, weighs $9.99 price, Bloomberg says »

Mark Gurman , Anousha…

AAPL

Apple

$212.30

1.98 (0.94%)

NFLX

Netflix

$300.38

-9.02 (-2.92%)

AMZN

Amazon.com

$1,813.54

-2.75 (-0.15%)

DIS

Disney

$135.22

-0.11 (-0.08%)

T

AT&T

$35.18

-0.225 (-0.64%)

CMCSA

Comcast

$44.37

0.38 (0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Oct

  • 27

    Oct

EPD

Enterprise Products

$29.29

0.35 (1.21%)

12:06
08/20/19
08/20
12:06
08/20/19
12:06
Conference/Events
Enterprise Products management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

CNI

Canadian National

$92.40

-0.76 (-0.82%)

12:05
08/20/19
08/20
12:05
08/20/19
12:05
Conference/Events
Canadian National management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 04

    Sep

  • 22

    Oct

  • 13

    Nov

URBN

Urban Outfitters

$21.10

0.24 (1.15%)

12:05
08/20/19
08/20
12:05
08/20/19
12:05
Options
Urban Outfitters call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 25

    Sep

BHGE

Baker Hughes

$21.00

-0.43 (-2.01%)

12:04
08/20/19
08/20
12:04
08/20/19
12:04
Hot Stocks
Baker Hughes awarded contract, granted notice to proceed by Venture Global LNG »

Baker Hughes (BHGE)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

VRTX

Vertex

$186.23

-0.84 (-0.45%)

12:02
08/20/19
08/20
12:02
08/20/19
12:02
Recommendations
Vertex analyst commentary at Piper Jaffray »

Piper Jaffray…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

MSG

Madison Square Garden

$266.70

-26.315 (-8.98%)

12:00
08/20/19
08/20
12:00
08/20/19
12:00
Hot Stocks
Madison Square Garden falls -9.0% »

Madison Square Garden is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

SE

Sea Limited

$32.53

-3.58 (-9.91%)

12:00
08/20/19
08/20
12:00
08/20/19
12:00
Hot Stocks
Sea Limited falls -9.9% »

Sea Limited is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.